Targeting Rare Diseases
AOP Orphan is a European pioneer in the development, marketing and distribution of medicines for people with rare and complex diseases.
Team Members
“Many patients with a rare disease suffer from a massive diagnostic delay. Our ambition is to shorten this way by raising disease awareness in cooperation with health care professionals and providing individual solutions to improve their life quality.”
“With specific cardiovascular expertise and highly innovative drugs, being able to improve clinical outcome of critically ill patients in acute and intensive care settings - that motivates me every day, together with committed colleagues, to achieve top performance in a renowned company.”
“As a an agile team we cumulate our knowledge, experience and hand-on approach to insure that the patients with rare diseases get a relieving treatment!”
“Have been working in hematology and oncology for more than twelve years, I have the wonderful chance to share these experiences with highly skilled and motivated colleagues at AOP Orphan for the benefit of Austrian patients. We work together to change patients lives in a positive way!”
“Our employees are the key to our success. With our highly selective products we can save lives at the crucial moment like in sepsis. This is my motivation.
Experienced team, courageous openness and mutual trust lead to good cooperation and set the standard for AOP Orphan Intensive Care!”
Facts & Figures
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Austrian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
Austria occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 1996 and this is where AOP Orphan also has its broad and solid base with a head office. AOP Orphan Austria is a team of around twelve employees in the Marketing & Sales, and Medical for all three therapeutic divisions.
HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders as well as Intensive Care.
Vision & Mission
